1. PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all

   • Evan A. Stein

   EDITORIAL 26 September 2016 Pages: 427 - 431

2. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles

   • Elaine N. Daminelli
   • Ana E. M. Martinelli
   • Raul C. Maranhão

   ORIGINAL ARTICLE 15 September 2016 Pages: 433 - 443

   

3. Exogenous Administration of Recombinant MIF at Physiological Concentrations Failed to Attenuate Infarct Size in a Langendorff Perfused Isolated Mouse Heart Model

   • Xavier Rossello
   • Niall Burke
   • Derek M. Yellon

   ORIGINAL ARTICLE Open access 22 June 2016 Pages: 445 - 453

   

4. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation

   • Dandan Wang
   • Yingguang Shan
   • Congxin Huang

   ORIGINAL ARTICLE 05 September 2016 Pages: 455 - 464

   

5. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial

   • Carlo Briguori
   • Rosalinda Madonna
   • Raffaele De Caterina

   ORIGINAL ARTICLE 29 June 2016 Pages: 465 - 472

   

6. Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher

   • Henry N. Ginsberg
   • Daniel J. Rader
   • Erik Stroes

   ORIGINAL ARTICLE Open access 13 September 2016 Pages: 473 - 483

   

7. Amiodarone Compared with Lidocaine for Out-Of-Hospital Cardiac Arrest with Refractory Ventricular Fibrillation on Hospital Arrival: a Nationwide Database Study

   • Takashi Tagami
   • Hiroki Matsui
   • Hideo Yasunaga

   ORIGINAL ARTICLE 13 September 2016 Pages: 485 - 491

   

8. Insulin in Acute Coronary Syndrome: a Narrative Review with Contemporary Perspectives

   • Michael C. Y. Nam
   • Christopher D. Byrne
   • Kim Greaves

   REVIEW ARTICLE 12 August 2016 Pages: 493 - 504

   

9. New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications

   • Nathan E. K. Procter
   • Nicola L. Hurst
   • John D. Horowitz

   REVIEW ARTICLE 29 June 2016 Pages: 505 - 513

   

10. Prevention of Contrast-Induced Acute Kidney Injury: an Update

    • George Chalikias
    • Ioannis Drosos
    • Dimitrios N. Tziakas

    OriginalPaper 19 August 2016 Pages: 515 - 524

11. Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data

    • Lisandro D. Colantonio
    • Shia T. Kent
    • Paul Muntner

    ORIGINAL ARTICLE 07 July 2016 Pages: 525 - 533

    

12. Reviewers for Cardiovascular Drugs and Therapy in 2015

    • ᅟ ᅟ

    ACKNOWLEDGEMENTS 01 September 2016 Pages: 535 - 536

13. Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia

    • Robert S. Rosenson
    • Terry A. Jacobson
    • Michael Miller

    Erratum 06 August 2016 Pages: 537 - 537